KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Other Non Operating Income: 2009-2017

Historic Other Non Operating Income for Teva Pharmaceutical Industries (TEVA) over the last 9 years, with Dec 2017 value amounting to -$65.0 million.

  • Teva Pharmaceutical Industries' Other Non Operating Income rose 101.36% to $600,000 in Q4 2015 from the same period last year, while for Dec 2015 it was -$27.4 million, marking a year-over-year increase of 8.67%. This contributed to the annual value of -$65.0 million for FY2017, which is 232.65% down from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Other Non Operating Income stood at -$65.0 million for FY2017, which was down 232.65% from $49.0 million recorded in FY2016.
  • Teva Pharmaceutical Industries' Other Non Operating Income's 5-year high stood at $49.0 million during FY2016, with a 5-year trough of -$65.0 million in FY2017.
  • Moreover, its 3-year median value for Other Non Operating Income was $9.0 million (2015), whereas its average is -$2.3 million.
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' Other Non Operating Income slumped by 275.00% in 2014, and later skyrocketed by 444.44% in 2016.
  • Over the past 5 years, Teva Pharmaceutical Industries' Other Non Operating Income (Yearly) stood at -$8.0 million in 2013, then plummeted by 275.00% to -$30.0 million in 2014, then skyrocketed by 130.00% to $9.0 million in 2015, then soared by 444.44% to $49.0 million in 2016, then slumped by 232.65% to -$65.0 million in 2017.